-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
U.S. Stem Cell, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2014 to 2022.
- U.S. Stem Cell, Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2022 was $0.000.
- U.S. Stem Cell, Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2022 was $0.000.
- U.S. Stem Cell, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
- U.S. Stem Cell, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
- U.S. Stem Cell, Inc. annual Income Tax Expense (Benefit) for 2020 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)